Company No: 07575796 (England and Wales)

Contents

• Company Information
• Balance Sheet
• Notes to the Financial Statements

DIRECTOR

S M Beeching

SECRETARY

S M Beeching

REGISTERED OFFICE	Salatin House
	19 Cedar Road
	Sutton
	SM2 5DA
	United Kingdom

COMPANY NUMBER

07575796 (England and Wales)

ACCOUNTANT	Shaw Gibbs Limited
	Salatin House
	19 Cedar Road
	Sutton
	Surrey
	SM2 5DA

	Note	2026		2025
		£		£
Fixed assets
Tangible assets	5	2,758		1,420
		2,758		1,420
Current assets
Debtors	6	21,663		19,345
Cash at bank and in hand	7	4,679		9,828
		26,342		29,173
Creditors: amounts falling due within one year	8	( 28,409)		( 28,710)
Net current (liabilities)/assets		(2,067)		463
Total assets less current liabilities		691		1,883
Net assets		691		1,883
Capital and reserves
Called-up share capital	9	1		1
Profit and loss account		690		1,882
Total shareholder's funds		691		1,883

For the financial year ending 31 March 2026 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• The member has not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Profit and Loss Account has not been delivered.

The financial statements of Oshun Partnership Limited (registered number: 07575796) were approved and authorised for issue by the Director on 06 October 2026. They were signed on its behalf by:

S M Beeching Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Oshun Partnership Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Salatin House, 19 Cedar Road, Sutton, SM2 5DA, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The director has assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Profit and Loss Account in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Fixtures and fittings	4 years straight line
Office equipment	4 years straight line

Depreciation methods, useful lives and residual values are reviewed at each balance sheet date. The selection of these residual values and estimated lives requires the exercise of judgement. The directors are required to assess whether there is an indication of impairment to the carrying value of assets. In making that assessment, judgements are made in estimating value in use. The directors consider that the individual carrying values of assets are supportable by their value in use.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

2. Critical accounting judgements and key sources of estimation uncertainty

The preparation of financial statements requires the use of certain critical accounting estimates. It also requires management to exercise its judgement in the process of applying the company accounting policies. The areas involving a higher degree of judgement or complexity, or areas where assumptions and estimates are significant to the financial statements are disclosed within the individual accounting policies above.

3. Employees

	2026		2025
	Number		Number
Monthly average number of persons employed by the Company during the year, including the director	1		1

4. Dividends on equity shares

	2026		2025
	£		£
Amounts recognised as distributions to equity holders in the financial year:
Interim dividend for the financial year ended 31 March 2026 of £38,000 (2025: £38,800) per ordinary share	38,000		38,800

5. Tangible assets

	Fixtures and fittings		Office equipment		Total
	£		£		£
Cost
At 01 April 2025	2,770		4,780		7,550
Additions	0		2,416		2,416
At 31 March 2026	2,770		7,196		9,966
Accumulated depreciation
At 01 April 2025	2,770		3,360		6,130
Charge for the financial year	0		1,078		1,078
At 31 March 2026	2,770		4,438		7,208
Net book value
At 31 March 2026	0		2,758		2,758
At 31 March 2025	0		1,420		1,420

6. Debtors

	2026		2025
	£		£
Trade debtors	18,336		19,345
Amounts owed by director	2,979		0
VAT recoverable	348		0
	21,663		19,345

.

7. Cash and cash equivalents

	2026		2025
	£		£
Cash at bank and in hand	4,679		9,828

8. Creditors: amounts falling due within one year

	2026		2025
	£		£
Amounts owed to director	0		30
Accruals	19,646		20,704
Taxation and social security	8,763		7,976
	28,409		28,710

9. Called-up share capital

	2026		2025
	£		£
Allotted, called-up and fully-paid
1 A ordinary share of £ 1.00	1		1

10. Related party transactions

Transactions with the entity's director

As at 31 March 2026, S M Beeching owed the company £ 2,979 (2025 : S M Beeching was owed £ 30 by the company). The loan is interest free and had no fixed repayment schedule.